Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 24, Issue 5, Pages 1238-1244
Publisher
Oxford University Press (OUP)
Online
2013-01-10
DOI
10.1093/annonc/mds636
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progression-Free Survival: Meaningful or Simply Measurable?
- (2012) Christopher M. Booth et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Poor correlation between progression-free and overall survival in modern clinical trials: Are composite endpoints the answer?
- (2011) Eitan Amir et al. EUROPEAN JOURNAL OF CANCER
- Consistency in the Analysis and Reporting of Primary End Points in Oncology Randomized Controlled Trials From Registration to Publication: A Systematic Review
- (2011) Benoit You et al. JOURNAL OF CLINICAL ONCOLOGY
- Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
- (2011) Javier Cortes et al. LANCET
- Reporting and Interpretation of Randomized Controlled Trials With Statistically Nonsignificant Results for Primary Outcomes
- (2010) Isabelle Boutron JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- When Are "Positive" Clinical Trials in Oncology Truly Positive?
- (2010) A. Ocana et al. JNCI-Journal of the National Cancer Institute
- Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
- (2010) Luca Gianni et al. LANCET
- Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer
- (2010) Miguel Martín et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bias Due to Changes in Specified Outcomes during the Systematic Review Process
- (2010) Jamie J. Kirkham et al. PLoS One
- Adverse Events in Randomized Trials
- (2009) John P. A. Ioannidis ARCHIVES OF INTERNAL MEDICINE
- Reporting of Safety Results in Published Reports of Randomized Controlled Trials
- (2009) ARCHIVES OF INTERNAL MEDICINE
- Endpoints for Assessing Drug Activity in Clinical Trials
- (2008) R. Pazdur ONCOLOGIST
- Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias
- (2008) Kerry Dwan et al. PLoS One
- Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation
- (2008) Kristin Rising et al. PLOS MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search